Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...

The rule would prevent many cereal and yogurt products from making nutrition claims and allow nuts, oils and certain seafood ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...

The FDA has developed draft guidance addressing confusion and legal action over the naming and labeling of plant-based alternatives to eggs, ...

Authorities this week updated the tuna recall to a Class II incident, warning it could become contaminated with a rare, potentially fatal bacteria.

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Lipocine (LPCN) announced that the FDA has recently informed sponsors of approved testosterone products about class-wide labeling changes. This ...

Complications with the implant used to treat blood vessel dissection after balloon angioplasty or stent placement can result ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

A bipartisan Senate bill dubbed the “Skinny Label, Big Savings Act” was introduced in January. The bill would expand the scope of protection ...